IPO - GLOBAL EAGLE CHINA LIFE TECHNOLOGY CO.,LIMITED

Form Type: DRS

Filing Date: 2025-04-16

Corporate Action: Ipo

Type: New

Accession Number: 000198676325000001

Filing Summary: GLOBAL EAGLE CHINA LIFE TECHNOLOGY CO.,LIMITED is offering ordinary shares as part of its initial public offering (IPO) on the Nasdaq Capital Market under the symbol 'NOI'. The expected offering price is $5.00 per share, and the commencement of the proposed sale is expected to occur after the effective date of the registration statement. The company is presented as an emerging growth company with reduced reporting requirements and intends to leverage these exemptions. The document outlines the risks associated with investing, specifically concerning the regulatory environment in China where the company operates through subsidiaries. It emphasizes the potential adverse effects from Chinese governmental actions, particularly in light of new cybersecurity laws and scrutiny of foreign investments. The company is described as a holding entity without direct operations in China, raising concerns about its structure amidst regulatory uncertainties. The summary also highlights the company’s focus on health management solutions utilizing innovative technologies, positioning itself within the pharmaceutical food industry and chronic disease management.